CLINICAL_TRIALS
trial_result
· 2025-09-05
Clinical Trial Update: Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis [Phase 2]
Summary
Phase 2 maximal-use study results for Tapinarof Cream 1% in pediatric patients with extensive atopic dermatitis have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-09-05